Medication management is one of the most frequently cited concerns in CQC inspection reports — and one of the most common triggers for Warning Notices under Regulation 12 (Safe Care and Treatment). The consequences of medication errors in care settings are serious: wrong doses, missed medications, or administration to the wrong resident can cause significant harm. The CQC takes these failures extremely seriously, and care homes that receive a Warning Notice related to medication must respond with immediate, systemic action.
This guide explains what CQC inspectors look for when assessing medication management, the most common issues that trigger Warning Notices, and exactly what care homes must do to demonstrate compliance.
| Why does medication management trigger so many CQC Warning Notices?
Medication management in care homes is complex, involves vulnerable residents, and touches almost every aspect of safe care — procurement, storage, administration, recording, disposal, and the management of errors. It is an area where systemic failures can directly harm residents. The CQC’s inspection methodology places medication management at the centre of the Safe key question, and inspectors are trained to identify both individual errors and the systemic failures that produce them. |
What CQC Inspectors Assess in Medication Management
When the CQC inspects a care home’s medication management, inspectors review:
Medication Administration Records (MARs)
MARs are the primary documentary evidence of medication administration. Inspectors look for:
- Gaps in administration — residents who should have received medication but have no record of receiving it
- Missing signatures — unsigned administration entries that cannot be verified
- Incorrect quantities — where the number of tablets administered does not match the prescribed dose
- Unauthorised amendments — alterations to MARs that are not countersigned or explained
- Historical MARs — inspectors typically review MARs going back several months, not just the current cycle
Controlled Drug Management
Controlled drugs (CDs) are subject to stricter legal requirements under the Misuse of Drugs Act 1971 and associated regulations. Inspectors check:
- Whether a separate controlled drug register is maintained
- Whether CD administration requires two signatures and whether both are present for every administration
- Whether CD stock levels in the register balance with physical stock
- Whether discrepancies are recorded and investigated
- Whether CD destruction is witnessed and recorded
Controlled drug discrepancies are treated with particular seriousness. A single unexplained discrepancy can trigger a Warning Notice.
Storage Conditions
Medicines must be stored appropriately:
- Locked medicines trolleys and medicine rooms, with restricted key access
- Temperature monitoring of the medicines room and any medicines requiring refrigeration, with records maintained
- Segregation of internal medicines from topical preparations and homely remedies
- Safe disposal of expired or discontinued medicines
Medication Administration Practice
Inspectors may observe medication rounds directly. They assess whether:
- Staff administering medication are trained and competency-assessed
- The “five rights” of medication administration are followed (right resident, right medicine, right dose, right route, right time)
- Staff are using appropriate reference resources (BNF, prescriber instructions) when needed
- Residents are given appropriate information about their medication and have their consent sought where required
Prescription Management
- Are prescriptions current and signed? Inspectors check that medicines are still prescribed and that prescriptions have not expired
- Are PRN (as required) protocols in place? Inspectors look for documented protocols explaining when, how, and in what dose PRN medicines should be administered, with evidence that these are followed
- Are dose administration aids (dossette boxes, blister packs) managed correctly, with appropriate MAR sheets?
Error Recording and Learning
Even care homes with good medication management make occasional errors. What the CQC assesses is:
- Whether errors are consistently recorded in a medication error log
- Whether errors are reviewed and analysed for patterns
- Whether learning from errors is shared with staff
- Whether significant errors are reported via the Datix/incident reporting system and appropriate duty of candour applied
The Most Common Medication-Related Warning Notice Triggers
| Issue | Why the CQC Treats It Seriously |
| Gaps in MAR completion | Unable to confirm residents received prescribed medication |
| CD discrepancies | Potential diversion of controlled drugs; direct risk to residents |
| Untrained staff administering medication | Direct risk of error; regulatory breach of Regulation 18 (staffing) |
| Temperature monitoring failures | Medicines may be ineffective or harmful if stored incorrectly |
| No PRN protocols | PRN medicines administered inconsistently, without clear guidance |
| Errors not recorded or investigated | Failure to learn; systemic risk not identified |
What a Care Home Must Do After a Medication Warning Notice
Immediate Actions (Day 1–7)
- Audit all current MARs for gaps, errors, and unsigned entries — document findings
- Complete an immediate CD stock check and reconcile against the register — investigate any discrepancy the same day
- Check all staff are trained and currently competency-assessed for medication administration — suspend any staff administering medication without current competency sign-off
- Check medicine storage temperatures for the previous 30 days — investigate any excursions
- Review all PRN protocols — update any that are absent, generic, or out of date
Systemic Actions (Weeks 2–6)
- Revise the Medication Management Policy to address the specific failures identified
- Implement a daily or weekly medication audit process — not just a monthly one
- Implement a double-check system for high-risk medicines
- Schedule refresher training and re-competency assessment for all staff
- Review the medication error recording and investigation process
- Strengthen the governance oversight of medication management — include medication as a standing agenda item at management meetings
Evidence for the Follow-Up Inspection
For each action, collect evidence that can be presented to inspectors:
- Completed audit forms showing the current state of MAR completion
- CD register with reconciled entries and no unexplained discrepancies
- Competency assessment records for all staff
- Revised Medication Management Policy (dated and version-controlled)
- Training attendance records
- Temperature monitoring logs
- Governance meeting minutes showing discussion of medication safety
Understanding the broader context of CQC Fundamental Standards helps registered managers see medication management as part of the overall Safe picture the CQC is assessing, rather than an isolated compliance task.
Our CQC Compliance & Ongoing Support service includes medication management systems reviews as part of our quality assurance programme, ensuring that care homes maintain compliance between inspections rather than only responding to regulatory pressure.
| Book a Free Consultation |
| If your care home has received a CQC Warning Notice related to medication management, Elberra Consulting can help you develop a structured response and prepare for your follow-up inspection. Book a Free Consultation →
Book your free consultation → elberraconsulting.co.uk/free-consultation/ |
Frequently Asked Questions
Can a single medication error trigger a CQC Warning Notice?
A single medication error rarely triggers a Warning Notice on its own — unless it caused serious harm or involved a controlled drug discrepancy. What inspectors typically find is a pattern: multiple gaps in MARs, recurring errors not being recorded or investigated, systemic failures in training or oversight. A Warning Notice reflects a systemic finding rather than a single incident, though a severe incident can trigger a responsive inspection that uncovers systemic issues.
Must I report medication errors to the CQC?
You must notify the CQC of any incident that has or could have affected the safety of people using your service, under Regulation 16 (Receiving and Acting on Complaints) and more specifically Regulation 18 of the CQC (Registration) Regulations 2009. For significant medication errors involving harm to a resident, you also have Duty of Candour obligations under Regulation 20.
Can agency staff administer medication in our care home?
Agency staff can administer medication provided they hold the same training and competency assessment as your substantive staff. You must verify their competency before allowing them to administer — do not assume that an agency will have done this adequately. Failure to verify agency staff competency for medication administration is a recurrent CQC finding.
What is a PRN protocol and why does the CQC require one?
A PRN (pro re nata, meaning “as required”) protocol is a documented guide for administering medication that is prescribed to be given as needed rather than at fixed times — for example, pain relief or anxiety medication. Without a protocol, different staff may administer PRN medication inconsistently, in different doses, or without appropriate assessment. The CQC requires that every PRN medicine has a protocol specific to the resident describing when to administer, what dose to give, and what outcome to assess for.
